Skip to main content
Download PDF
  • Research article
  • Open access
  • Published:

1,25-Dihydroxyvitamin D3 modulates the phenotype and function of Monocyte derived dendritic cells in cattle

BMC Veterinary Research volume 13, Article number: 390 (2017) Cite this article

Abstract

Background

The active form of the vitamin D3, 1,25-Dihydroxyvitamin D3 (1,25-(OH)2D3) has been shown to have major effects not only on physiological processes but also on the regulation of the immune system of vertebrates. Dendritic cells are specialised antigen presenting cells which are in charge of the initiation of T-cell dependant immune responses and as such are key regulators of responses towards pathogens. In this study we set out to evaluate the effects of 1,25-(OH)2D3 on the phenotype of cattle monocyte-derived dendritic cells (MoDCs) and how the conditioning with this vitamin affects the function of these myeloid cells.

Results

MoDCs were generated from CD14+ monocytes with bovine IL-4 and GM-CSF with or without 1,25-(OH)2D3 supplementation for 10 days. Vitamin D conditioned MoDCs showed a reduced expression of co-stimulatory and antigen presenting molecules, as well as a reduced capability of endocytose ovalbumin. Furthermore, the capacity of MoDCs to induce proliferation in an allogeneic mixed leukocyte reaction was abolished when MoDCs were generated in presence of 1,25-(OH)2D3. LPS induced maturation of 1,25-(OH)2D3conditioned MoDCs resulted in lower secretion of IL-12 and higher IL-10 than that observed in MoDCs.

Conclusions

The typical immunotolerant phenotype observed in cattle DCs after exposure to 1,25-(OH)2D3 has a significant effect on the functionality of these immune cells, inhibiting the T-cell stimulatory capacity of MoDCs. This could have profound implications on how the bovine immune system deals with pathogens, particularly in diseases such as tuberculosis or paratuberculosis.

Background

Dendritic cells (DCs) are professional antigen-presenting cells (APC) which act as a bridge between innate and adaptive immune responses. DCs patrol the periphery of the immune system in an immature state where they use their unique specialised function to capture and process antigens. Once they receive this maturation signal, they migrate to lymphoid organs and, by secreting cytokines and chemokines, expressing co-stimulatory molecules in their surface and presenting antigens to T cells, are able to initiate a cascade of immune responses [1]. However, DCs not only activate primary immune responses against foreign antigens, they also differentiate non-self from self-antigens and by inducing immunological tolerance in T cells, are able to control autoimmune responses which have the potential to damage the host. The depletion of DCs in animal models breaks self-tolerance of CD4+ T cells and is associated with the onset of fatal autoimmune diseases [2].

Given that the induction of immunotolerance could be used to prevent undesirable immune responses for individuals with autoimmune diseases or undergoing transplantations, these cells are being investigated for their potential use as therapeutic targets [3,4,5]. However, studying the function of DCs in different species can be hampered by the difficulties which arise during the isolation and identification of these cells. Not only are there various DC phenotypes depending on the tissue where they are found, but they also express different markers in different species [6,7,8,9]. However, monocytes can be differentiated into dendritic cells (MoDCs) by the addition of IL-4 and GM-CSF [10, 11]. As their function and phenotype are typical of immature DCs, MoDCs are a good substitute to freshly isolated DCs and can be used as in vitro models of innate immune responses.

Recent studies have revealed that the active form of the vitamin D3, 1,25-Dihydroxyvitamin D3 (1,25-(OH)2D3), can play an important role in calcium and bone homeostasis and the regulation of the immune system [12,13,14,15,16,17,18]. The immune modulatory functions of vitamin D include the regulation of genes involved in host immune defense such as antimicrobial peptides [15], the prevention of the onset of autoimmune diseases models [19], or inhibition of the production of inflammatory cytokines in response to inflammatory or infectious stimuli [20]. However, as an immunomodulator, this hormone can also affect the function and development of monocytes and dendritic cells. As professional antigen presenting cells, DCs require the production of IL-12 to drive naïve T cell to a Th1 phenotype and recent studies have shown a reduction in secretion of IL-12 by DCs which have been treated with high doses of 1,25-(OH)2D3, leading to an overall reduced functionality [16, 21]. Furthermore, 1,25-(OH)2D3 is able to down-regulate the expression of MHC-II and co-stimulatory molecules in DCs as well as modulate their cytokine production.

The majority of studies investigating the effects of 1,25-(OH)2D3 on DCs and the immune system have been carried out in humans [5, 16] or mice [22, 23], with only a few studies carried out in veterinary species. In poultry, Vitamin D has been shown to inhibit proliferation and IFN-γ production by lymphocytes [14], while the addition of 1,25-(OH)2D3 to chicken macrophages up-regulates the production of nitric oxide by 5-fold, consequently improving the phagocytic nature of these cells [24]. In ruminants, the majority of the work investigating the effects of vitamin D has been focused on nutritional aspects [25], although the role of vitamin D in reproductive fitness [26] and infectious diseases such as bovine tuberculosis [27] and mastitis [28] has also been investigated. In Mycobacterium bovis infected cattle it has been shown that 1,25-(OH)2D3 can inhibit M. bovis-specific proliferation of CD4+ and γδ T cells [29, 30]. Furthermore, activation of the vitamin D pathway using a monoclonal antibody to the vitamin D receptor has been shown to suppress M. bovis-specific proliferation and interferon gamma (IFN-γ) production of peripheral blood mononuclear cells [27]. In this latter study the suppressive effects were associated with a down-regulation of CD80 expression, suggesting that activation of the vitamin D pathway was associated with a deficiency in antigen presenting cell (APC) function. However, in contrast to work in mice and humans there have been no studies specifically addressing the effects of vitamin D on ruminant APC phenotype and functionality.

In this study we investigate the immunomodulatory effects of 1,25-(OH)2D3 on cattle DCs. We generated Vitamin D conditioned MoDCs by differentiating bovine CD14 monocytes with IL-4 and GM-CSF in the presence of 1,25-(OH)2D3 (VitD-MoDCs). We then examined the phenotype and functionality of these VitD-MoDCs and compared to that of standard MoDCs.

Methods

Animals

Healthy 6-months old Holstein-Friesian and Ayrshire calves were purchased from two Scottish commercial dairy farms and maintained at Moredun Research Institute (MRI), UK. All animals were kept off pasture for the duration of the experiments. All experiments were approved by the Ethics Committee at MRI and were performed to Home Office Guidelines under Project Licence (PPL 60/3854).

Isolation of bovine PBMC and in vitro generation of Monocyte derived Dendritc cells (MoDCs)

Blood was collected aseptically into 350 ml blood bags containing 45 ml of Citrate phosphate dextrose-adenine 1 (CPDA-1) stabiliser (Sarstedt, Germany). PBMC were isolated as previously described [31] using density gradient centrifugation by layering whole blood diluted with phosphate buffered saline (PBS) onto Ficoll-Paque™ PLUS (GE Healthcare Life Sciences). Buffy coat was collected and washed three times with PBS and re-suspended in MACS Buffer [PBS + 0.5% foetal bovine serum (FBS, from USA supplied by Sigma-Aldrich, UK)]. CD14 monocytes were positively selected by incubation of PBMC with CD14 MicroBeads (clone TÜK4, Miltenyi Biotech, Germany) in cold MACS buffer for 15 min at 4 °C. Cell-microbead complex were washed twice, resuspended in 3 ml of MACS buffer and purified over an LS column as per manufacturer’s instructions. Purified CD14 monocytes were washed to eliminate any residual microbeads and resuspended in tissue culture medium (RPMI-1640 medium) supplemented with 10% FBS and 50 μM 2-mercaptoethanol, 2 mM L-glutamine, 100 U/ml Penicillin and 100 μg/ml Streptomycin (all from Sigma-Aldrich, UK). Enrichment purity was consistently above 95% as assessed by flow cytometry. Monocyte derived dendritic cells (MoDC) were generated in the presence of bovine GM-CSF and IL-4 (Bovine Dendritic Cell Growth kit, Bio-Rad) for 10 days as previously described [13, 31] with some modifications. Briefly, purified cattle monocytes were seeded in 6-well plates at a concentration of 106cells/ml. Cells were cultured in the presence of 50 μl/ml of Bovine DC Growth Kit and 10 nM 1,25-(OH)2D3for Vitamin D3 conditioned MoDCs (VitD-MoDCs), or 50 μl/ml of Bovine DC Growth Kit only for MoDCs. Fresh medium, cytokines and 1,25-(OH)2D3 where applicable were replenished on day 3 and 6 of culture. Cells were harvested on day 10.

Phenotype of MoDCs and VitD-MoDCs

Single colour flow cytometric analysis was carried out to phenotype bovine MoDCs and VitD conditioned MoDCs. After 10 days of culture as detailed above, cells were harvested and following a 10 min blocking step with 20% normal goat serum (NGS, Bio-Rad) in PBS, incubated with the following un-conjugated monoclonal antibodies: CD1b (CC14, Bio-Rad), CD80 (IL-A159, Bio-Rad), CD86 (IL-A190, Bio-Rad) and MHCII-DR (CC108, Bio-Rad) at pre-optimised concentrations for 20 min. Cells were then washed twice with FACS buffer (PBS + 5%FBS + 0.05%NaN3) and further incubated for 20 min with a secondary anti-mouse IgG mAb conjugated to Alexa-Fluor® 647 (Invitrogen, Life Technologies, US). After two washes, cells were resuspended in the dead cell stain Sytox Blue (Invitrogen, Life Technologies, US) and immediately a minimum of 10,000 events were acquired using a MACSQuant® Analyzer 10 (Miltenyi Biotech, Germany). Post acquisition gating, including dead cell and doublet cell discrimination, and analysis were carried out using FlowJo vX for Windows 7. Phase contrast images of MoDC and VitD-MoDCs were captured using an Axiovert 200 M inverted microscope (Carl Zeiss Ltd., UK).

Endocytosis by MoDCs and VitD-MoDCs

One of the main roles of DCs is the sampling of their environment for antigens through endocytosis. Consequently, to assess the effect of 1,25-(OH)2D3 enrichment on endocytosis, we used DQ-Ovalbumin (DQ-OVA, Molecular Probes, Life Technologies, US), a self-quenched conjugate which exhibits bright green fluorescence upon proteolytic degradation yielding a low background signal. Hence, 105 MoDCs or VitD conditioned MoDCs were incubated with 10 μg/ml of DQ-OVA or medium only for 1 h at 37 °C. After incubation, cells were washed 3 times with FACS buffer and resuspended in Sytox Blue (ThermoFisher) prior to flow cytometry analysis as detailed above.

Mixed leukocyte reaction

In order to define the capability of VitD conditioned MoDCs to stimulate an alloreactive mixed leukocyte reaction (allo-MLR) an experiment was set up using two animals from different breeds which showed high proliferation in preliminary MLRs. PBMC obtained from an Ayrshire calf were used as responder cells, whilst MoDCs generated from a Holstein-Friesian calf were used as the allogeneic stimulators. MoDCs and VitD-MoDCs were generated for 10 days as described earlier and stimulated with or without LPS for 24 h. Cells were harvested and irradiated (60Gy) to ensure that detected proliferation was derived only from PBMCs. Irradiated MoDCs were then resuspended in complete medium with 10% FBS at a concentration of 105cells/ml. Responder PBMC (105 per well) were incubated with irradiated MoDCs/VitDMoDCs at the following ratios, 1:10, 1:20, 1:100, 1:200, 1:400 and 1:1000. Reactions were set up in quadruplicate in U-well microtitre plates in a total volume of 200 μl. Controls consisted of responder PBMC or irradiated stimulator cells in medium alone or with 5 μg/ml of Concanavalin A (ConA, Sigma-Aldrich). Cells were incubated at 37 °C for 4 days after which 50 μl of medium was collected from each replicate/treatment and replenished with fresh complete medium containing methyl-3H thymidine (0.5 μCi per well; Amersham Biosciences UK Ltd., Chalfont St. Giles, Buckinghamshire). Proliferation was measured by the incorporation of methyl-3H thymidine during the final 18 h of culture as previously described [32]. Data are presented as the corrected counts per minute (ccpm) averaged over 3 min.

Cytokine secretion after LPS stimulation

MoDCs and 1,25(OH)2D3 conditioned MoDCs were harvested on day 10 and incubated with 1 μg/ml of LPS (0111:B4, Sigma UK) or medium only for 24 h. After stimulation supernatants were collected to analyse cytokine secretion induced by LPS. Capture ELISAs were performed to examine the secretion of IL-1β (Anti-Bovine IL-1β polyclonal capture and detection antibodies, BioRad), IL-10 (clones CC318 and CC320b, BioRad) and IL-12 (clones CC301 and CC326b, BioRad). Standard curves were constructed using recombinant bovine IL-1β (BioRad) and transfected COS-7 cells supernatants for IL-10 [33] or IL-12 [34]. All incubations were carried out at room temperature unless stated and washing steps were performed 6 times with 350 μl washing buffer (PBS + 0.05% Tween 20) using a Thermo Scientific Wellwash™ Versa (ThermoFisher). Briefly, high-binding capacity ELISA plates (Immunolon™ 2HB 96-well microtiter plates, ThermoFisher) plates were coated with capture antibodies at pre-optimised concentrations and incubated over night at 4 °C. Plates were then washed and blocked for 1 h with PBS+ 3% Bovine Serum Albumin (BSA, Sigma). Following a further washing step, 50 μl of supernatants or standards were added in duplicate for 1 h. Plates were then washed and detection antibodies added for 1 h. This was followed by washing and addition of Streptavidin-HRP (Sigma) for 45 min. After the final washing step, 50 μl of SureBlue TMB substrate (Insight Biotechnology, London, UK) was added and the reaction was stopped by the addition of H2SO4. Absorbance values were read at O.D. 450 nm. All values were blanked corrected and concentrations determined from standard curve.

Statistical analysis

Statistical analyses were performed using the non-parametric test Kruskal-Wallis and a Dunns multiple comparison post hoc test in the case of not normally distributed data or One-Way ANOVA and a Tukey post hoc test when data were normally distributed. All analyses were carried out within the Minitab version 17 statistical package, with p < 0.05 considered significant.

Results

1,25(OH)2D3 conditioning influences the phenotype and endocytic capabilities of bovine MoDCs

Monocytes were incubated with boIL-4 and boGM-CSF alone or with 1,25-(OH)2D3 for a period of 10 days. All cultures were set up with the same starting monocyte number, but interestingly, the supplementation of MoDCs with 1,25-(OH)2D3 during differentiation clearly improved the survival of the MoDCs. Typically, after the 10 day culture period, around 4.6 times more cells were recovered from the 1,25-(OH)2D3 conditioned cultures than those differentiated with IL-4 + GM-CSF only (cell recovery expressed as percentage of starting population: 6–30% in MoDCs vs 25–100% in VitD-MoDCs; Fig. 1), showing the need for supplementation with 1,25-(OH)2D3 throughout the differentiation process. In order to determine if 1,25(OH)2D3 conditioning affected the phenotype and function of MoDCs, we initially investigated the expression of antigen presenting and co-stimulatory molecules which are typically up-regulated in CD14 monocytes cultured with GM-CSF and IL-4 alone. As expected, MoDCs expressed high levels of CD1b, CD80, CD86 and MHC-II (Fig. 2). However, when MoDCs were supplemented with 1,25(OH)2D3 during differentiation, the expression of all four markers remained consistently lower than in MoDCs. Although this reduced MFI was observed for all four markers, only CD1b was significantly down-regulated in VitD-MoDCs when compared to MoDCs (p = 0.016).

Fig. 1
figure 1

Cattle CD14 + ve monocytes differentiated in the presence of 1,25 (OH)2D3. MoDCs were generated as detailed in Material and Methods with or without 1,25(OH)2D3. All treatments were seeded at a 106cells/ml and supplemented with boIL-4, boGM-CSF with or without 10 nM of 1,25(OH)2D3 on day 1, day 3 and day 6 of culture. Cells were harvested on day 10. Phase contrast images of MoDCs with (a) or without (b) 1,25 (OH)2D3 depicts an increased proportion of cells in wells containing cells differentiated in the presence of 1,25(OH)2D3

Full size image
Fig. 2
figure 2

Phenotype of cattle MoDCs differentiated in the presence or absence of 1,25 (OH)2D3. Phenotype of MoDCs or 1,25 (OH)2D3 conditioned MoDCS derived from cattle CD14 + ve monocytes was analysed by flow cytometry. MoDCs were single stained with primary mAbs to CD1b, CD80, CD86 or MHC-II DR and then stained with Alexa Fluor 647 IgG secondary antibody. Live, single gated cells were assessed for expression of these markers. a Data shown are the average ± the SE of the corrected median fluorescence intensity (MFI) for MoDCs (black bars) and 1,25 (OH)2D3 conditioned MoDCS (white bars). b Histogram for a representative animal showing the level of uptake of expression of chosen markers for MoDCs (black histograms) or 1,25 (OH)2D3 conditioned MoDCS (grey histograms). *denotes statistical significance for p < 0.05

Full size image

Immature DCs have the ability to efficiently uptake antigens by endocytosis, consequently in order to assess the endocytic capacity of the VitD-MoDCs, we investigated the uptake of the model antigen ovalbumin (OVA), a protein taken up by clathrin-coated pits in dendritic cells [35]. 1,25(OH)2D3 conditioned MoDCs and MoDCs and were incubated with DQ-OVA for 1 h, after which cells were harvested and analysed by flow cytometry. A significantly lower level of internalisation and processing of OVA was observed in VitD-MoDCs when compared MoDCs (Fig. 3, p = 0.025).

Fig. 3
figure 3

The endocytic capabilities of cattle MoDCs are diminished by conditioning with 1,25(OH)2D3. MoDCs were differentiated from cattle CD14 monocytes in the absence (black bars) or presence (white bars) of 1,25(OH)2D3 for 10 days. After harvesting, cells were incubated for 1 h with DQ-OVA and uptake analysed by flow cytometry. Live, single cells were gated and the MFI of each treatment calculated. The results shown are average ± SE of two animals representing the DQ MFI for uptake by MoDCs and 1,25(OH)2D3 conditioned MoDCs. * denotes statistical significance for p < 0.05

Full size image

Impaired ability of 1,25(OH)2D3 conditioned MoDC to induce lymphocyte proliferation

We then tested the influence of 1,25(OH)2D3 conditioning in the ability of MoDCs to induce lymphocyte proliferation in an allo-MLR following LPS maturation. Unstimulated MoDCs were able to significantly increase spontaneous proliferation of PBMC at ratios of 1:10, 1:20 and 1:100 of MoDCs to PBMC (p = 0.009, p = 0.001, p = 0.021 respectively, Fig. 4). In contrast, the incorporation of thymidine by PBMC incubated with unstimulated MoDCs conditioned with 1,25(OH)2D3 remained below the level of spontaneous proliferation of PBMC only controls (dashed line in Fig. 4), even at high stimulator:responder ratios. This difference was enhanced up to 7-fold when both cell types were matured with LPS prior to setting up the MLR. While LPS stimulated MoDCs were able to generate a high level of proliferation in lymphocytes with as little as 103 MoDCs per 105 PBMC, LPS-stimulated VitD-MoDCs were unable to induce a convincing PBMC proliferative response at any of the MoDC:PBMC ratios tested (LPS VitD conditioned MoDCs vs LPS MoDCS; at 1:10, p < 0.001, at 1:20, p < 0.001, and at 1:100, p = 0.021).

Fig. 4
figure 4

MoDCs differentiated in the presence of 1,25(OH)2D3 are not able to induce an allogeneic mixed leukocyte reaction. MoDCs differentiated from cattle CD14 monocytes in the presence or absence of 1,25(OH)2D3 for 10 days. After harvesting, cells incubated with or without LPS for 24 h. Following stimulation, cells were irradiated and cultured in quadruplicate at different ratios with 105responder PBMC for 5 days. Responder PBMC and stimulator MoDCs were incubated in medium only or with ConA (5μg/ml) as controls of proliferation. Proliferation was measured by the incorporation of methyl-3H thymidine ([3H]TdR; 0.5 μCi per well) for the final 18 h of culture. Data are presented as the corrected counts per minute (ccpm) averaged over 3 min. Data shown are the representative of two independent experiments with error bars denoting ± SE. Dashed line denotes the spontaneous proliferation of PBMC with no ConA/stimulator cells. * denotes statistical significance for p < 0.05, ** p value between 0.001 and 0.01 and *** for p < 0.001

Full size image

1,25(OH)2D3 enhances LPS driven IL-10 production by MoDCs

As professional APCs, the main function of DCs is the activation of naive T cells. In order to do so, DCs process antigens and present them on their surface to the T cells. Furthermore, the secretion of cytokines by MoDCs is able to influence the phenotype of the T cells they activate [36]. Consequently, we analysed the LPS induced cytokine secretion by MoDCs differentiated in the presence or absence of 1,25(OH)2D3 after a stimulation period of 24 h. There was no significant difference in the secretion of any of the cytokines between resting MoDCs and VitD-MoDCs (Fig. 5). However, after a 24 h stimulation with LPS, the secretion of IL-1β, IL-10 and IL-12 was significantly upregulated both by MoDCs or VitD-MoDCs (Fig. 5a, b, c; all p = 0.009). This LPS driven cytokine secretion was consistently higher in VitD-MoDCs for all three cytokines (all p = 0.0122) when compared to MoDCs. When expressed as a fold increase in cytokine release relative to the unstimulated controls, the fold increase in IL-1β secretion by 1,25-(OH)2D3 conditioned MoDCs was 21.4, while the fold increase for MoDCs was only 6.5 (Fig. 5e, p<0.0001). The opposite could be seen for IL-12 secretion, where the MoDCs produced significantly more cytokine than its vitamin D conditioned counterpart (Fig. 5e, p=0.01). No significant differences were observed in the fold increase in IL-10 secretion between MoDCs and VitD-MoDCs (Fig. 5e). However, when expressed as a ratio of IL-10/IL-12, MoDCs cells secreted higher levels of IL-12 in comparison to IL-10 after LPS stimulation compared to the 1,25-(OH)2D3 conditioned MoDCs (Fig. 5d; p < 0.0001).

Fig. 5
figure 5

Cytokine secretion by cattle MoDCs differentiated in the presence or absence of 1,25(OH)2D3. MoDCs differentiated from cattle CD14 + ve monocytes in the presence or absence of 1,25(OH)2D3 for 10 days. After harvesting, cells incubated with (white bars) or without LPS (black bars) for 24 h. Following stimulation, secretion of IL-1β (a), IL-12 (b) and IL-10 (c) into culture supernatants were measured by ELISA. Data are expressed as the concentration of cytokine in picograms (pg) or biological units (BU) per ml of supernatant. (d) Fold increase of cytokine secretion. (e) Ratio of IL10/IL12 secretion. Results are shown as the mean values with error bars indicating ± SE from four animals. * denotes statistical significance for p < 0.05, ** p value between 0.001 and 0.01 and *** for p < 0.001

Full size image

Discussion

The influence of 1,25-(OH)2D3 on the function of immune cells has been widely discussed, from their effects on the central nervous system [13], to the modulation of innate immune responses by macrophages [28], or the induction of tolerogenic DCs [16, 18, 22]. However, little information is available on the immunomodulatory effects of 1,25-(OH)2D3 in ruminants or how they obtain this hormone from the environment.

When exploring the effect of vitamin D3 at a cellular level, some studies have focused on its ability to inhibit mitogen or antigen induced secretion of IFNγ in bovine lymphocytes [30, 37], while others have shown that when 1,25-(OH)2D3 is added to bovine monocyte cultures infected with Mycobacterium bovis, NO production is enhanced and apoptosis of antigen-stimulated cells reduced [30]. The production of 1,25-(OH)2D3 by bovine monocytes has also been reported to modulate iNOS and RANTES expression in LPS stimulated monocytes [38]. However, there is currently little evidence regarding how 1,25-(OH)2D3 affects other key immune cells such as DCs, which are required to activate naive T cells in order to trigger an effective immune response.

Here we show the profound effects that are caused by 1,25-(OH)2D3 conditioning during the differentiation of bovine MoDCs. Bovine MoDCs have a distinct phenotype when compared to afferent lymph DCs [35, 39], they express co-stimulatory molecules such as CD1b and MHCII at a higher level than CD14 monocytes all of which are required for antigen presentation. When we investigated the phenotype of MoDCs differentiated in the presence or absence of 1,25-(OH)2D3, the expression of both markers was lower in the 1,25-(OH)2D3 conditioned MoDCs, particularly CD1b. This is in agreement with work carried out in other mammalian species, such as human [16, 40] or mice [21], indicating that the presence of 1,25-(OH)2D3 in the culture medium is able to hinder the complete differentiation of monocytes into MoDCs. Reports on the expression of CD86 and CD80 have been more inconsistent. In some cases CD86 was lowly expressed by VitD-MoDCs and CD80 was unaffected [16]; in other cases, the expression of both cell surface markers is lower when MoDCs are differentiated with 1,25-(OH)2D3 [23]. During the present study the addition of 1,25-(OH)2D3 from day 0 impeded the same level of upregulation of CD80 and CD86 seen in MoDCs, a trend seen for all four markers investigated.

The ability to take up antigens is a crucial biological function of dendritic cells. When encountering an antigen, APCs are able to process antigens via the endocytic pathway and present them to quiescent naive T cells, initiating a cascade of immune responses [41]. Consequently, in order to examine if 1,25-(OH)2D3 conditioned MoDCs are able to endocytose antigens, we investigated the uptake of OVA by clathrin-coated pits [31, 35]. As in human [16, 42], bovine 1,25-(OH)2D3 conditioned MoDCs are functionally impaired for endocytosis, as a significantly lower level of internalisation of OVA could be observed when compared to cells incubated without vitamin D during the differentiation process.

The key function of DCs, antigen presentation, was not only affected phenotypically by the supplementation of MoDCs with 1,25-(OH)2D3, but also functionally as seen by the suppression of the T-cell stimulatory capacity in 1,25-(OH)2D3 conditioned MoDCs. Five days after incubation with allogeneic PBMC, MoDCs were able to induce proliferation with numbers as low as 103 MoDCs per 105 PBMC. However, 1,25-(OH)2D3 conditioned MoDCs were never able to induce a proliferation higher than background proliferation measured by PBMC incubated in medium only. When maturation was driven by stimulation with LPS for a period of 24 h, this T-cell stimulatory capacity was enhanced in MoDCs while conditioned MoDCs remained lower than the background proliferation. This correlation between phenotype and T-cell stimulatory capacity has been seen in other species [16, 23, 40, 43] and confirms that vitamin D3 also fails to activate cattle dendritic cells. Upon TLR4 activation, we also observed a clear up-regulation of IL-12 secretion both in MoDCs and in 1,25-(OH)2D3 conditioned MoDCs. However, when investigated further, the fold increase in IL-12 with MoDCs was double that seen in 1,25-(OH)2D3 conditioned MoDCs, a difference also reflected by the low IL-10/IL-12 ratio in MoDCs. Vitamin D3 has been shown to have a negative effect on the production of IL-12 MoDCs after exposure to LPS in human studies [16, 43]. As IL-12 is the main cytokine which drives Th1 differentiation in naive T cells [36], the reduction we observed in IL-12 secretion by 1,25-(OH)2D3 conditioned MoDCs after LPS stimulation, suggests that these Vitamin D conditioned cells may induce a reduced Th1 phenotype in the T cells they activate.

Secretion of IL-10 by DCs has an important role in immunosuppressive responses and is key to the differentiation of CD4+ type 1 T-regulatory (Tr1) cells [44, 45]. Consistent with other murine and human studies [16, 22, 23, 43], we demonstrated that 1,25-(OH)2D3 conditioned MoDCs secrete relatively higher levels of IL-10 and lower of IL-12 than MoDCs. This indicates a clear suppressing action of vitamin D3 on DC development which is able to drive a typical immunotolerant phenotype on cattle DCs. The implications of this on adaptive immune responses in vivo is unclear, although it is known that co-immunization of antigens with supplementary vitamin D results in class-switching of B cells to IgA, suggesting this vitamin can play an important role in modulating bovine adaptive immune responses in vivo [46].

Cattle obtain vitamin D3 from either the diet or from photoconversion of 7-dehydrocholesterol in the skin following exposure to UV light from sunlight [47]. As common grassland plants do not contain vitamin D3, skin is the principle source of this vitamin in grazing cattle [48]. However, in current agricultural systems a significant proportion of cattle are house under conditions with little or no sunlight and therefore dietary supplementation of vitamin D, usually in the form of vitamin D3, is required [25, 49]. Supplementation guidelines are available for cattle which provide daily vitamin D requirements for different classes and ages of cattle [50]. However, these recommendations are largely based on levels of vitamin D required to maintain calcium balance rather than immune function. As vitamin D acts in an endocrine manner for calcium homeostasis, but an intracrine and paracrine manner for many of the non-calcaemic functions of vitamin D [51], it is possible that the requirements of vitamin D for calcium homeostasis and immune function may differ. Consequently current recommendations for vitamin D supplementation in cattle may not be sufficient for optimal immune function. Given the growing body of evidence that vitamin D can modulate immunity in cattle, future research should focus on determining the optimum concentrations of vitamin D3 required for immune function, and how variables associated with vitamin D3 synthesis in the skin, such as quantity and UV light exposure to the skin, the levels of skin 7-dehydrocholesterol, and skin pigmentation [52], as well as different dietary levels of dietary supplementation of vitamin D, affects the immunity and health status of cattle.

Conclusion

In summary, the present work demonstrates that conditioning of monocytes with the hormone 1,25-(OH)2D3 during the monocyte to DC maturation process induces a semi-mature or immunotolerant DC phenotype. As a consequence, the antigen presenting capabilities of these cells is hampered as shown by the reduced ability to endocytose ovalbumin and the inability to induce lymphocyte proliferation in the context of a mixed leukocyte reaction. The effects of Vitamin D3-mediated modulation of DC function (both MoDCs and the recently described bovine blood DCs [53]) on pathogen-specific T cell responses should now be investigated, particularly in the context of diseases such as bovine tuberculosis for which a key role for Vitamin D3 has been proposed [27].

Abbreviations

1,25-(OH)2D3:

1,25-Dihydroxyvitamin D3

allo-MLR:

Allogeneic Mixed Leukocyte Reaction

ANOVA:

Analysis of variance

APC:

Antigen presenting cell

BSA:

Bovine serum albumin

CPDA-1:

Citrate phosphate dextrose-adenine 1

DC:

Dendritic cells

FBS:

Foetal bovine serum

GM-CSF:

Granulocyte macrophages colony-stimulating factor

HRP:

Horseradish peroxidase

IFN-γ:

Interferon gamma

IgA:

Immunoglobulin A

IL-10:

Interleukin-10

IL-12:

Interleukin-12

IL-1β:

Interleukin-1 beta

IL-4:

Interleukin 4

iNOS:

Inducible nitric oxide synthase

LPS:

Lipopolysaccharide

MACS:

Magnetic-activated cell sorting

MFI:

Median fluorescence intensity

MHC-II:

Major histocompatibility complex type II

MoDC:

Monocyte derived dendritic cells

NGS:

Normal goat serum

OVA:

Ovalbumin

PBMC:

Peripheral mononuclear cells

PBS:

Phosphate buffed saline

RANTES:

Regulated on activation, normal t cell expressed and secreted

Th1:

T helper 1

Tr1:

T-regulatory

UV:

Ultraviolet

VitD-MoDCs:

Vitamin D conditioned monocyte derived

References

  1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392

  2. Ohnmacht C, Pullner A, King SBS, Drexler I, Meier S, Brocker T, Voehringer D. Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J Exp Med. 2009;206(3):549–59.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Lüssi F, Zipp F, Witsch E. Dendritic cells as therapeutic targets in neuroinflammation. Cell Mol Life Sci. 2016;73(13):2425–50.

    Article  Google Scholar 

  4. Khan S, Greenberg JD, Bhardwaj N. Dendritic cells as targets for therapy in rheumatoid arthritis. Nat Rev Rheumatol. 2009;5(10):566–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Naranjo-Gómez M, Raïch-Regué D, Oñate C, Grau-López L, Ramo-Tello C, Pujol-Borrell R, Martínez-Cáceres E, Borràs FE. Comparative study of clinical grade human tolerogenic dendritic cells. J Transl Med. 2011;9(1):89.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Contreras V, Urien C, Guiton R, Alexandre Y, Vu Manh T-P, Andrieu T, Crozat K, Jouneau L, Bertho N, Epardaud M, et al. Existence of CD8α-like Dendritic cells with a conserved functional specialization and a common molecular signature in distant mammalian species. J Immunol. 2010;185(6):3313–25.

    Article  CAS  PubMed  Google Scholar 

  7. Marquet F, Bonneau M, Pascale F, Urien C, Kang C, Schwartz-Cornil I, Bertho N. Characterization of Dendritic cells subpopulations in skin and afferent lymph in the swine model. PLoS One. 2011;6(1):e16320.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Vu Manh T-P, Bertho N, Hosmalin A, Schwartz-Cornil I, Dalod M. Investigating evolutionary conservation of Dendritic cell subset identity and functions. Front Immunol. 2015;6:260.

    PubMed  PubMed Central  Google Scholar 

  9. Guilliams M, Henri S, Tamoutounour S, Ardouin L, Schwartz-Cornil I, Dalod M, Malissen B. From skin dendritic cells to a simplified classification of human and mouse dendritic cell subsets. Eur J Immunol. 2010;40(8):2089–94.

    Article  CAS  PubMed  Google Scholar 

  10. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 1994;179(4):1109–18.

    Article  CAS  PubMed  Google Scholar 

  11. Chan SSM, McConnell I, Blacklaws BA. Generation and characterization of ovine dendritic cells derived from peripheral blood monocytes. Immunology. 2002;107(3):366–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Adorini L. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes. Ann N Y Acad Sci. 2003;987:258–61.

    Article  CAS  PubMed  Google Scholar 

  13. Besusso D, Saul L, Leech MD, O’Connor RA, MacDonald AS, Anderton SM, Mellanby RJ. 1,25-Dihydroxyvitamin D(3)-conditioned CD11c+ Dendritic cells are effective initiators of CNS autoimmune disease. Front Immunol. 2015;6:575.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Boodhoo N, Sharif S, Behboudi S. 1α,25(OH)2 vitamin D3 modulates avian T lymphocyte functions without inducing CTL unresponsiveness. PLoS One. 2016;11(2):e0150134.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Heulens N, Korf H, Mathyssen C, Everaerts S, De Smidt E, Dooms C, Yserbyt J, Gysemans C, Gayan-Ramirez G, Mathieu C, et al. 1,25-Dihydroxyvitamin D modulates antibacterial and inflammatory response in human cigarette smoke-exposed macrophages. PLoS One. 2016;11(8):e0160482.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Piemonti L, Monti P, Sironi M, Fraticelli P, Leone BE, Dal Cin E, Allavena P, Di Carlo V. Vitamin D3 affects differentiation, maturation, and function of human Monocyte-derived Dendritic cells. J Immunol. 2000;164(9):4443.

    Article  CAS  PubMed  Google Scholar 

  17. Xing N, L Maldonado ML, Bachman LA, DJ MK, Kumar R, Griffin MD. Distinctive dendritic cell modulation by vitamin D(3) and glucocorticoid pathways. Biochem Biophys Res Commun. 2002;297(3):645–52.

    Article  CAS  PubMed  Google Scholar 

  18. Adorini L, Penna G. Induction of Tolerogenic Dendritic cells by vitamin D receptor agonists. In: Lombardi G, Riffo-Vasquez Y, editors. Dendritic cells. Berlin, Heidelberg: Springer Berlin Heidelberg; 2009. p. 251–73.

    Chapter  Google Scholar 

  19. Lemire JM. Immunomodulatory actions of 1,25-Dihydroxyvitamin D3. J Steroid Biochem Mol Biol. 1995;53(1–6):599–602.

    Article  CAS  PubMed  Google Scholar 

  20. Zhang Y, Leung DYM, Richers BN, Liu Y, Remigio LK, Riches DW, Goleva E. Vitamin D inhibits Monocyte/macrophage Proinflammatory cytokine production by targeting MAPK Phosphatase-1. J Immunol. 2012;188(5):2127–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Griffin MD, Lutz W, Phan VA, Bachman LA, McKean DJ, Kumar R. Dendritic cell modulation by 1α,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci. 2001;98(12):6800–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Ferreira GB, Gysemans CA, Demengeot J, da Cunha JPMCM, Vanherwegen A-S, Overbergh L, Van Belle TL, Pauwels F, Verstuyf A, Korf H, et al. 1,25-Dihydroxyvitamin D3 promotes Tolerogenic Dendritic cells with functional migratory properties in NOD mice. J Immunol. 2014;192(9):4210–20.

    Article  CAS  PubMed  Google Scholar 

  23. Ferreira GB, van Etten E, Verstuyf A, Waer M, Overbergh L, Gysemans C, Mathieu C. 1,25-Dihydroxyvitamin D3 alters murine dendritic cell behaviour in vitro and in vivo. Diabetes Metab Res Rev. 2011;27(8):933–41.

    Article  CAS  PubMed  Google Scholar 

  24. Morris A, Selvaraj RK. In vitro 25-hydroxycholecalciferol treatment of lipopolysaccharide-stimulated chicken macrophages increases nitric oxide production and mRNA of interleukin- 1beta and 10. Vet Immunol Immunopathol. 2014;161(3–4):265–70.

    Article  CAS  PubMed  Google Scholar 

  25. Nelson CD, Lippolis JD, Reinhardt TA, Sacco RE, Powell JL, Drewnoski ME, O’Neil M, Beitz DC, Weiss WP. Vitamin D status of dairy cattle: outcomes of current practices in the dairy industry. J Dairy Sci. 2016;99(12):10150–60.

    Article  CAS  PubMed  Google Scholar 

  26. Handel I, Watt KA, Pilkington JG, Pemberton JM, Macrae A, Scott P, McNeilly TN, Berry JL, Clements DN, Nussey DH, Mellanby RJ. Vitamin D status predicts reproductive fitness in a wild sheep population. Scientific Reports 2016; 6:18986.

  27. Rhodes SG, Terry LA, Hope J, Hewinson RG, Vordermeier HM. 1,25-Dihydroxyvitamin D(3) and development of tuberculosis in cattle. Clin Diagn Lab Immunol. 2003;10(6):1129–35.

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Nelson CD, Reinhardt TA, Beitz DC, Lippolis JD. In vivo activation of the Intracrine vitamin D pathway in innate immune cells and mammary tissue during a bacterial infection. PLoS One. 2010;5(11):e15469.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Waters WR, Nonnecke BJ, Foote MR, Maue AC, Rahner TE, Palmer MV, Whipple DL, Horst RL, Estes DM. Mycobacterium Bovis bacille Calmette–Guerin vaccination of cattle: activation of bovine CD4+ and γδ TCR+ cells and modulation by 1,25-dihydroxyvitamin D3. Tuberculosis. 2003;83(5):287–97.

    Article  CAS  PubMed  Google Scholar 

  30. Waters WR, Nonnecke BJ, Rahner TE, Palmer MV, Whipple DL, Horst RL. Modulation of Mycobacterium Bovis-specific responses of bovine peripheral blood mononuclear cells by 1,25-Dihydroxyvitamin D3. Clin Diagn Lab Immunol. 2001;8(6):1204–12.

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Corripio-Miyar Y, Hope J, McInnes CJ, Wattegedera SR, Jensen K, Pang Y, Entrican G, Glass EJ. Phenotypic and functional analysis of monocyte populations in cattle peripheral blood identifies a subset with high endocytic and allogeneic T-cell stimulatory capacity. Vet Res. 2015;46(1):1–19.

    Article  Google Scholar 

  32. McNeilly TN, Rocchi M, Bartley Y, Brown JK, Frew D, Longhi C, McLean L, McIntyre J, Nisbet AJ, Wattegedera S, et al. Suppression of ovine lymphocyte activation by Teladorsagia circumcincta larval excretory-secretory products. Vet Res. 2013;44(1):1–18.

    Article  Google Scholar 

  33. Kwong LS, Hope JC, Thom ML, Sopp P, Duggan S, Bembridge GP, Howard CJ. Development of an ELISA for bovine IL-10. Vet Immunol Immunopathol. 2002;85

  34. Hope JC, Kwong LS, Entrican G, Wattegedera S, Vordermeier HM, Sopp P, Howard CJ. Development of detection methods for ruminant interleukin (IL)-12. J Immunol Methods. 2002;266(1–2):117–26.

    Article  CAS  PubMed  Google Scholar 

  35. Werling D, Hope JC, Chaplin P, Collins RA, Taylor G, Howard CJ. Involvement of caveolae in the uptake of respiratory syncytial virus antigen by dendritic cells. J Leukoc Biol. 1999;66(1):50–8.

    CAS  PubMed  Google Scholar 

  36. Macatonia SE, Hosken NA, Litton M, Vieira P, Hsieh CS, Culpepper JA, Wysocka M, Trinchieri G, Murphy KM, O'Garra A. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol. 1995;154(10):5071–9.

    CAS  PubMed  Google Scholar 

  37. Ametaj BN, Beitz DC, Reinhardt TA, Nonnecke BJ. 1,25-Dihydroxyvitamin D3 inhibits secretion of interferon-γ by mitogen- and antigen-stimulated bovine mononuclear leukocytes. Vet Immunol Immunopathol. 1996;52(1):77–90.

    Article  CAS  PubMed  Google Scholar 

  38. Nelson CD, Reinhardt TA, Thacker TC, Beitz DC, Lippolis JD. Modulation of the bovine innate immune response by production of 1α,25-dihydroxyvitamin D3 in bovine monocytes. J Dairy Sci. 2010;93(3):1041–9.

    Article  CAS  PubMed  Google Scholar 

  39. Howard CJ, Sopp P, Brownlie J, Kwong LS, Parsons KR, Taylor G. Identification of two distinct populations of dendritic cells in afferent lymph that vary in their ability to stimulate T cells. J Immunol. 1997;159(11):5372–82.

    CAS  PubMed  Google Scholar 

  40. Canning M, Grotenhuis K, de Wit H, Ruwhof C, Drexhage H. 1-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes. Eur J Endocrinol. 2001;145(3):351–7.

    Article  CAS  PubMed  Google Scholar 

  41. Mellman I, Turley SJ, Steinman RM. Antigen processing for amateurs and professionals. Trends Cell Biol. 1998;8(6):231–7.

    Article  CAS  PubMed  Google Scholar 

  42. Berer A, Stöckl J, Majdic O, Wagner T, Kollars M, Lechner K, Geissler K, Oehler L. 1,25-Dihydroxyvitamin D3 inhibits dendritic cell differentiation and maturation in vitro. Exp Hematol. 2000;28(5):575–83.

    Article  CAS  PubMed  Google Scholar 

  43. Chamorro S, García-Vallejo JJ, Unger WWJ, Fernandes RJ, Bruijns SCM, Laban S, Roep BO, 't Hart BA, van Kooyk Y: TLR triggering on Tolerogenic Dendritic cells results in TLR2 up-regulation and a reduced Proinflammatory immune program. J Immunol 2009, 183(5):2984-2994.

  44. Corthay A. How do regulatory T cells work? Scand J Immunol. 2009;70(4):326–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Levings MK, Gregori S, Tresoldi E, Cazzaniga S, Bonini C, Roncarolo MG. Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. Blood. 2005;105(3):1162–9.

    Article  CAS  PubMed  Google Scholar 

  46. Vilte DA, Larzábal M, Garbaccio S, Gammella M, Rabinovitz BC, Elizondo AM, Cantet RJC, Delgado F, Meikle V, Cataldi A, et al. Reduced faecal shedding of Escherichia Coli O157:H7 in cattle following systemic vaccination with γ-intimin C280 and EspB proteins. Vaccine. 2011;29(23):3962–8.

    Article  CAS  PubMed  Google Scholar 

  47. Hymøller L, Jensen SK. 25-Hydroxycholecalciferol status in plasma is linearly correlated to daily summer pasture time in cattle at 56°N. Br J Nutr. 2012;108(4):666–71.

    Article  PubMed  Google Scholar 

  48. Hymøller L, Jensen SK. Vitamin D3 synthesis in the entire skin surface of dairy cows despite hair coverage. J Dairy Sci. 2010;93(5):2025–9.

    Article  PubMed  Google Scholar 

  49. Hidiroglou M, Karpinski K. Providing vitamin D to confined sheep by oral supplementation vs ultraviolet irradiation. J Anim Sci. 1989;67(3):794–802.

    Article  CAS  PubMed  Google Scholar 

  50. NRC: National Research Council (U.S.) subcommittee on dairy cattle nutrition: nutrient requirements of dairy cattle. In. Edited by Press NA, 7th revised edition edn. Washington, D.C.; 2001.

  51. Hewison M. Vitamin D and the intracrinology of innate immunity. Mol Cell Endocrinol. 2010;321(2):103–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Norman AW, Henry HC. Vitamin D. In: Zempleni J, Rucker RB, DB MC, Suttle JW, editors. Handbook of vitamins. 4th ed. Boca Raton: CRC Press; 2007.

    Google Scholar 

  53. Park KT, ElNaggar MM, Abdellrazeq GS, Bannantine JP, Mack V, Fry LM, Davis WC. Phenotype and function of CD209+ bovine blood Dendritic cells, Monocyte-derived-Dendritic cells and Monocyte-derived macrophages. PLoS One. 2016;11(10):e0165247.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Not applicable

Funding

YCM was supported by European Union’s Horizon 2020 research and innovation programme under grant agreement No. 635408. TNM received funding from the Rural & Environment Science & Analytical Services Division of the Scottish Government. RJM was supported by a ‘Wellcome Trust Intermediate Clinical Fellowship’.

Availability of data and materials

All data generated or analysed during this study are included in this published article, and also available from the corresponding author on reasonable request.

Author information

Authors and Affiliations

  1. Moredun Research Institute, Pentlands Science Park, Bush Loan, Midlothian, UK

    Yolanda Corripio-Miyar, Katy Morrison & Tom N. McNeilly

  2. The Roslin Institute, Royal (Dick) School of Veterinary Studies, The University of Edinburgh, Midlothian, UK

    Richard J. Mellanby

Authors
  1. Yolanda Corripio-Miyar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richard J. Mellanby
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Katy Morrison
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tom N. McNeilly
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

YC-M, RM and TMN conceived the study and participated in its design. YC-M performed the experimental work and wrote the manuscript. KM assisted in the phenotyping and cytokine analysis. RM and TMN participated in the writing of the manuscript and its critical review. All co-authors revised the manuscript and approved the final submitted version.

Corresponding author

Correspondence to Tom N. McNeilly.

Ethics declarations

Ethics approval

All experiments were approved by The Moredun Experiments and Ethical Review Committee from the Moredun Research Institute and were performed to Home Office Guidelines under Project Licence (PPL 60/3854).

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Corripio-Miyar, Y., Mellanby, R.J., Morrison, K. et al. 1,25-Dihydroxyvitamin D3 modulates the phenotype and function of Monocyte derived dendritic cells in cattle. BMC Vet Res 13, 390 (2017). https://doi.org/10.1186/s12917-017-1309-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12917-017-1309-8

Keywords

BMC Veterinary Research

ISSN: 1746-6148

Contact us